Euro India Biotech Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
- Paid Up Capital ₹ 2.33 Cr
- Company Age 32 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Ebitda
- Net Worth
- Total Assets 0.37%
About Euro India Biotech
Euro India Biotech Limited (EIBL) is a Public Limited Indian Non-Government Company incorporated in India on 01 June 1992 and has a history of 32 years and eight months. Its registered office is in Chandigarh, India.
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 2.33 Cr, as per Ministry of Corporate Affairs (MCA) records.
Seema Chettri, Sudershan Goel, Anuj Goel, and Two other members serve as directors at the Company.
Company Details
-
Location
Chandigarh, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U29211CH1992PLC012332
-
Company No.
012332
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
01 Jun 1992
-
Date of AGM
22 Jul 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chandigarh
Industry
Who are the key members and board of directors at Euro India Biotech?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anuj Goel
|
Director | 22-Apr-2019 | Current |
|
Seema Chettri
|
Director | 01-Aug-2007 | Current |
|
Sudershan Goel
|
Director | 04-Mar-2019 | Current |
|
Anju Bala
|
Director | 05-Aug-2021 | Current |
|
Vikram Kang
|
Director | 03-Apr-2017 | Current |
Financial Performance of Euro India Biotech.
Euro India Biotech Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Euro India Biotech?
In 2019, Euro India Biotech had a promoter holding of 99.42% and a public holding of 0.58%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Swami Debananda Hospitality Private LimitedSeema Chettri, Sudershan Goel and 2 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Euro India Biotech?
Unlock and access historical data on people associated with Euro India Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Euro India Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Euro India Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
